Xiaoming Liu
About Xiaoming Liu
Xiaoming Liu is a scientist with extensive experience in biotechnology, currently working at both Bristol-Myers Squibb and Henlius in leadership roles.
Current Positions
Xiaoming Liu is currently holding dual roles in the pharmaceutical industry. He works as a Scientist at Bristol-Myers Squibb in Devens and also serves as a Director at Henlius in Shanghai, China. These positions demonstrate his expertise and leadership in the field of biotechnology.
Career at Bristol-Myers Squibb
Xiaoming Liu has a significant history with Bristol-Myers Squibb. His tenure began as an Associate Scientist I & II from 2016 to 2018, progressing to his current role as a Scientist in Devens. His career advancement at the company showcases his growing responsibilities and expertise.
Tenure at Cook Pharmica
Liu spent a total of 3 years and 5 months at Cook Pharmica, including a 5-month co-op position in 2013. He worked there as an Associate Scientist from 2013 to 2016, gaining valuable industry experience in Bloomington, Indiana. This role helped shape his foundational skills in the biotech industry.
Educational Background in Biotechnology
Xiaoming Liu has a strong educational background in biotechnology. He earned a Master’s degree from Northwestern University, where he studied from 2011 to 2013. Prior to that, he completed a Bachelor of Science in Biotechnology at Shanghai Jiao Tong University, where he studied from 2007 to 2011. This academic foundation has been pivotal in his professional achievements.
Experience in Tech Transfer Management
Liu has extensive experience in tech transfer management, which involves transferring scientific findings from research laboratories to commercial industry applications. This expertise is essential in his roles at Henlius and Bristol-Myers Squibb, facilitating the application of biotechnological innovations in real-world settings.
International Work Experience
Xiaoming Liu has cultivated a diverse career with international experience in both the United States and China. His work in Shanghai and Devens evidences his adaptability and understanding of global pharmaceutical industry dynamics. This international perspective enhances his capability in managing biotechnological projects across different markets.